Partial reprogramming of heterologous cells by defined factors to generate megakaryocyte lineage-restricted biomolecules

Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Yamanaka, 2008, Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors, Cell Prolif., 41, 51 Ma, 2013, Progress in the reprogramming of somatic cells, Circ. Res., 112, 562, 10.1161/CIRCRESAHA.111.249235 Kowalska, 2010, Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis, Thromb. Res., 125, 292, 10.1016/j.thromres.2009.11.023 Ferreira, 2005, GATA1 function, a paradigm for transcription factors in hematopoiesis, Mol. Cell. Biol., 25, 1215, 10.1128/MCB.25.4.1215-1227.2005 Lu, 2004, Properties of ets-1 binding to chromatin and its effect on platelet factor 4 gene expression, Mol. Cell. Biol., 24, 428, 10.1128/MCB.24.1.428-441.2004 Lulli, 2006, Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation, Cell Death Differ., 13, 1064, 10.1038/sj.cdd.4401811 Shivdasani, 2001, Molecular and transcriptional regulation of megakaryocyte differentiation, Stem Cells, 19, 397, 10.1634/stemcells.19-5-397 Tijssen, 2013, Transcription factors in late megakaryopoiesis and related platelet disorders, J. Thromb. Haemost., 11, 593, 10.1111/jth.12131 Hancock, 2010, Introducing undergraduate students to real-time PCR, Biochem. Mol. Biol. Educ., 38, 309, 10.1002/bmb.20414 Ravid, 1991, Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter, Proc. Natl. Acad. Sci. U. S. A., 88, 1521, 10.1073/pnas.88.4.1521 Moreau, 2016, Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming, Nat. Commun., 7, 11208, 10.1038/ncomms11208 Ono, 2012, Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf, Blood, 120, 3812, 10.1182/blood-2012-02-413617 Pulecio, 2016, Direct conversion of fibroblasts to megakaryocyte progenitors, Cell Rep., 17, 671, 10.1016/j.celrep.2016.09.036 Wechsler, 2002, Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome, Nat. Genet., 32, 148, 10.1038/ng955 Kuhl, 2005, GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1, Mol. Cell. Biol., 25, 8592, 10.1128/MCB.25.19.8592-8606.2005 Muntean, 2005, Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development, Blood, 106, 1223, 10.1182/blood-2005-02-0551 Zheng, 2010, GATA transcription factors and cancer, Genes Cancer, 1, 1178, 10.1177/1947601911404223 Wang, 2002, Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors, EMBO J., 21, 5225, 10.1093/emboj/cdf527 Bruns, 2014, Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion, Nat. Med., 20, 1315, 10.1038/nm.3707 Aivado, 2007, Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease, Proc. Natl. Acad. Sci. U. S. A., 104, 1307, 10.1073/pnas.0610330104 de Graaf, 2016, Haemopedia: an expression atlas of murine hematopoietic cells, Stem Cell Rep., 7, 571, 10.1016/j.stemcr.2016.07.007